.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Julphar
Harvard Business School
McKesson
Federal Trade Commission
Fish and Richardson
McKinsey
Merck
QuintilesIMS

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078191

« Back to Dashboard
NDA 078191 describes RAMIPRIL, which is a drug marketed by West-ward Pharms Int, Aurobindo Pharma Ltd, Cipla, Actavis Elizabeth, Sandoz, Apotex, Lupin, Zydus Pharms Usa, Invagen Pharms, Ranbaxy Labs Ltd, Watson Labs, Mylan Pharms Inc, Apotex Inc, Teva Pharms, Dr Reddys Labs Ltd, Accord Hlthcare, and Zydus Pharms Usa Inc, and is included in seventeen NDAs. It is available from thirty-three suppliers. Additional details are available on the RAMIPRIL profile page.

The generic ingredient in RAMIPRIL is ramipril. There are nineteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the ramipril profile page.

Summary for 078191

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 078191

Medical Subject Heading (MeSH) Categories for 078191

Suppliers and Packaging for NDA: 078191

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RAMIPRIL
ramipril
CAPSULE;ORAL 078191 ANDA Dr. Reddy's Laboratories Limited 55111-438 55111-438-01 100 CAPSULE in 1 BOTTLE (55111-438-01)
RAMIPRIL
ramipril
CAPSULE;ORAL 078191 ANDA Dr. Reddy's Laboratories Limited 55111-438 55111-438-05 500 CAPSULE in 1 BOTTLE (55111-438-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength1.25MG
Approval Date:Jun 18, 2008TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2.5MG
Approval Date:Jun 18, 2008TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:Jun 18, 2008TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Fuji
Accenture
QuintilesIMS
Dow
Queensland Health
Covington
Fish and Richardson
Medtronic
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot